Based on the Sonoma Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Sonoma Pharmaceuticals Inc is not available over the next 12 months. Sonoma Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sonoma Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Sonoma Pharmaceuticals Inc’s stock price was USD 2.22. Sonoma Pharmaceuticals Inc’s stock price has changed by -9.39% over the past week, -36.21% over the past month and -26.00% over the last year.
No recent analyst target price found for Sonoma Pharmaceuticals Inc
No recent average analyst rating found for Sonoma Pharmaceuticals Inc
Company Overview Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis; and Pediacyn, an atopic dermatitis hydrogel. It also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for use in emergencies and on mucous membranes, cuts, abrasions, burns, and body surfaces; and Endocyn root canal irrigation solutions. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. Read Less
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company of...Read More
Frequently Asked Questions About Sonoma Pharmaceuticals Inc (SNOA) Stock
Stock Target Advisor's fundamental analysis for Sonoma Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on SNOA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SNOA's stock to indicate what its average analyst target is.
SNOA stock's Price/Earning ratio is 2.60.
Our analysis grades SNOA stock's Price / Earning ratio at C. This means that SNOA stock's Price/Earning ratio is above 26% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange.
Based on this SNOA may be undervalued for its sector.
The last closing price of SNOA's stock was USD 2.22.
The most recent market capitalization for SNOA is USD 5.90M.
Unfortunately we do not have enough analyst data on SNOA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sonoma Pharmaceuticals Inc's stock.
As per our most recent records Sonoma Pharmaceuticals Inc has 10 Employees.
Sonoma Pharmaceuticals Inc's registered address is 5445 Conestoga Court, Boulder, CO, United States, 80301.
You can get more information about it from Sonoma Pharmaceuticals Inc's website at https://sonomapharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Sonoma Pharmaceuticals Inc (SNOA) Stock
Stock Target Advisor's fundamental analysis for Sonoma Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on SNOA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SNOA's stock to indicate what its average analyst target is.
SNOA stock's Price/Earning ratio is 2.60.
Our analysis grades SNOA stock's Price / Earning ratio at C. This means that SNOA stock's Price/Earning ratio is above 26% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange.
Based on this SNOA may be undervalued for its sector.
The last closing price of SNOA's stock was USD 2.22.
The most recent market capitalization for SNOA is USD 5.90M.
Unfortunately we do not have enough analyst data on SNOA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sonoma Pharmaceuticals Inc's stock.
As per our most recent records Sonoma Pharmaceuticals Inc has 10 Employees.
Sonoma Pharmaceuticals Inc's registered address is 5445 Conestoga Court, Boulder, CO, United States, 80301.
You can get more information about it from Sonoma Pharmaceuticals Inc's website at https://sonomapharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SNOA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
